Biosimilars have also made inroads among generic suppliers. But development is lengthy and expensive. McKinsey estimates that it costs $100 to $300 million to develop a biosimilar and that it takes ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する